TKUMF yields 5.46% · PFE yields 6.20%● Live data
📍 TKUMF pulled ahead of the other in Year 1
Combined, TKUMF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TKUMF + PFE for your $10,000?
Takuma Co., Ltd. engages in the design, construction, and superintendence of various boilers, plant machineries, pollution prevention and environmental equipment plants, heating and cooling equipment, and feed water/drainage sanitation equipment and facilities in Japan and internationally. It operates through four segments: Domestic Environment and Energy Business, Overseas Environment and Energy Business, Package Boiler Business, and Equipment and System Business. The Domestic Environment and Energy Business segment operates general waste treatment, industrial waste treatment, waste recycling, wastewater treatment, sludge combustion, and biomass power plants. The Overseas Environment and Energy Business segment operates waste combusting and biomass power plants. The Package Boiler Business segment offers compact through-flow boilers and vacuum water heating systems. The Equipment and System Business segment provides construction equipment, and equipment for the semiconductor industry and cleaning systems. The company was formerly known as Takuma Boiler Manufacturing Co., Ltd. and changed its name to Takuma Co., Ltd. in 1972. Takuma Co., Ltd. was incorporated in 1938 and is headquartered in Amagasaki, Japan.
Full TKUMF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.